Calcium folinate pentahydrate
B Acute Lymphoblastic Leukemia
SWOG Cancer Research NetworkSmall moleculePhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 67/ 100
- Competitive Position
- 73/ 100
Competitive context
33 Active assets in the B Acute Lymphoblastic Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
VINCRISTINE SULFATE City of Hope Medical Center | Phase 3 | BB |
PEGASPARGASE National Cancer Institute (NCI) | Phase 3 | BB |
MERCAPTOPURINE ANHYDROUS SWOG Cancer Research Network | Phase 3 | BB |
METHOTREXATE SWOG Cancer Research Network | Phase 3 | BB |
Cytosin-Arabinosid SWOG Cancer Research Network | Phase 3 | BB |
View all 42 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →